MKC vs. CVS
MKC (McCormick & Company, Incorporated) and CVS (CVS Health Corporation) are both stocks. MKC operates in Packaged Foods (Consumer Defensive), while CVS operates in Healthcare Plans (Healthcare). Over the past 10 years, MKC returned 1.31%/yr vs 2.37%/yr for CVS. At a 0.25 correlation, their price movements are largely independent.
Performance
MKC vs. CVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MKC achieves a -31.64% return, which is significantly lower than CVS's 14.70% return. Over the past 10 years, MKC has underperformed CVS with an annualized return of 1.31%, while CVS has yielded a comparatively higher 2.37% annualized return.
MKC
- 1D
- -0.92%
- 1M
- -8.14%
- YTD
- -31.64%
- 6M
- -28.35%
- 1Y
- -35.32%
- 3Y*
- -17.49%
- 5Y*
- -10.52%
- 10Y*
- 1.31%
CVS
- 1D
- -1.24%
- 1M
- 9.03%
- YTD
- 14.70%
- 6M
- 17.27%
- 1Y
- 45.87%
- 3Y*
- 12.84%
- 5Y*
- 3.94%
- 10Y*
- 2.37%
MKC vs. CVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MKC McCormick & Company, Incorporated | -31.64% | -8.33% | 13.97% | -15.68% | -12.65% | 2.67% | 14.70% | 23.65% | 39.01% | 11.34% |
CVS CVS Health Corporation | 14.70% | 84.35% | -40.77% | -12.53% | -7.63% | 54.87% | -5.14% | 17.26% | -7.04% | -5.75% |
Correlation
The correlation between MKC and CVS is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Mar 27, 1990 | 0.25 |
The correlation between MKC and CVS shifts across timeframes, from 0.10 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.
Fundamentals
MKC:
$12.43B
CVS:
$114.47B
MKC:
$6.10
CVS:
$2.30
MKC:
7.56
CVS:
38.88
MKC:
1.75
CVS:
0.28
MKC:
1.78
CVS:
1.48
MKC:
$7.11B
CVS:
$407.91B
MKC:
$2.70B
CVS:
$56.59B
MKC:
$1.22B
CVS:
$9.99B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MKC vs. CVS — Risk / Return Rank
MKC
CVS
MKC vs. CVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for McCormick & Company, Incorporated (MKC) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MKC | CVS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -1.27 | 1.50 | -2.77 |
Sortino ratioReturn per unit of downside risk | -1.83 | 1.93 | -3.76 |
Omega ratioGain probability vs. loss probability | 0.79 | 1.29 | -0.50 |
Calmar ratioReturn relative to maximum drawdown | -0.88 | 2.73 | -3.61 |
Martin ratioReturn relative to average drawdown | -1.84 | 7.06 | -8.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MKC | CVS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.27 | 1.50 | -2.77 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.44 | 0.13 | -0.57 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.05 | 0.08 | -0.03 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.33 | +0.10 |
Drawdowns
MKC vs. CVS - Drawdown Comparison
The maximum MKC drawdown since its inception was -52.02%, smaller than the maximum CVS drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for MKC and CVS.
Loading charts...
Drawdown Indicators
| MKC | CVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -52.02% | -64.07% | +12.05% |
Max Drawdown (1Y)Largest decline over 1 year | -39.50% | -16.44% | -23.06% |
Max Drawdown (3Y)Largest decline over 3 years | -47.65% | -43.98% | -3.67% |
Max Drawdown (5Y)Largest decline over 5 years | -52.02% | -56.79% | +4.77% |
Max Drawdown (10Y)Largest decline over 10 years | -52.02% | -56.79% | +4.77% |
Current DrawdownCurrent decline from peak | -51.44% | -8.78% | -42.66% |
Average DrawdownAverage peak-to-trough decline | -10.99% | -19.56% | +8.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.84% | 6.36% | +12.48% |
Volatility
MKC vs. CVS - Volatility Comparison
The current volatility for McCormick & Company, Incorporated (MKC) is 7.89%, while CVS Health Corporation (CVS) has a volatility of 10.91%. This indicates that MKC experiences smaller price fluctuations and is considered to be less risky than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MKC | CVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.89% | 10.91% | -3.02% |
Volatility (6M)Calculated over the trailing 6-month period | 23.14% | 26.02% | -2.88% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.93% | 30.74% | -2.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.30% | 29.90% | -5.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.17% | 29.28% | -5.11% |
Dividends
MKC vs. CVS - Dividend Comparison
MKC's dividend yield for the trailing twelve months is around 4.03%, more than CVS's 2.97% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CVS CVS Health Corporation | 2.97% | 3.35% | 5.93% | 3.06% | 2.36% | 1.94% | 2.93% | 2.69% | 3.05% | 2.76% | 2.15% | 1.43% |
MKC McCormick & Company, Incorporated | 4.03% | 2.69% | 2.24% | 2.32% | 1.81% | 1.44% | 1.68% | 1.37% | 1.53% | 1.89% | 1.89% | 1.91% |
Financials
MKC vs. CVS - Financials Comparison
This section allows you to compare key financial metrics between McCormick & Company, Incorporated and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MKC vs. CVS - Profitability Comparison
MKC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, McCormick & Company, Incorporated reported a gross profit of 708.90M and revenue of 1.87B. Therefore, the gross margin over that period was 37.8%.
CVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a gross profit of 15.62B and revenue of 100.43B. Therefore, the gross margin over that period was 15.6%.
MKC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, McCormick & Company, Incorporated reported an operating income of 227.50M and revenue of 1.87B, resulting in an operating margin of 12.1%.
CVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported an operating income of 4.68B and revenue of 100.43B, resulting in an operating margin of 4.7%.
MKC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, McCormick & Company, Incorporated reported a net income of 1.02B and revenue of 1.87B, resulting in a net margin of 54.2%.
CVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a net income of 2.94B and revenue of 100.43B, resulting in a net margin of 2.9%.
Frequently Asked Questions
MKC and CVS have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CVS has higher volatility (10.91%) compared to MKC (7.89%). In terms of maximum drawdown, MKC dropped -52.02% vs CVS's -64.07%.
CVS currently has the higher Sharpe Ratio (1.50 vs -1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MKC and CVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer